Clinical Research Directory
Browse clinical research sites, groups, and studies.
Collagen Crosslinking for Keratoconus - a Randomized Controlled Clinical Trial
Sponsor: Sahlgrenska University Hospital
Summary
The purpose of this study is to determine whether corneal collagen crosslinking is effective in the treatment of progressive keratoconus.
Key Details
Gender
All
Age Range
18 Years - 30 Years
Study Type
INTERVENTIONAL
Enrollment
36
Start Date
2012-05
Completion Date
2025-04
Last Updated
2024-06-06
Healthy Volunteers
No
Conditions
Interventions
Corneal Collagen Crosslinking
Keratoconic corneas that show significant progression as specified in the inclusion criteria section will receive one single treatment with CXL if randomized to the treatment arm. A treatment protocol based on 30 minutes dropping with riboflavin/dextran solution and 10 minutes UV-illumination treatment will be used.
Locations (1)
Department of Ophthalmology, Sahlgrenska University Hospital
Mölndal, Västra Götalandsregionen, Sweden